Skip to main content

J0577 HCPCS Level II Code: Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy

Medicare Coverage & Payment

  • CMS short descriptor: Inj, brixadi, 7 days or less
  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: April 1, 2024

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Change history

  • April 1, 2024
    Added to the code set
    Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $430.58

58284-0208-01 — Brixadi (weekly dosing) — Braeburn Inc. (size 0.16 × qty 1 (Less than or equal to 7 days of therapy per billing unit))

58284-0216-01 — Brixadi (weekly dosing) — Braeburn Inc. (size 0.32 × qty 1 (Less than or equal to 7 days of therapy per billing unit))

58284-0224-01 — Brixadi (weekly dosing) — Braeburn Inc. (size 0.48 × qty 1 (Less than or equal to 7 days of therapy per billing unit))

58284-0232-01 — Brixadi (weekly dosing) — Braeburn Inc. (size 0.64 × qty 1 (Less than or equal to 7 days of therapy per billing unit))

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J0577 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (35)

Change history

  • April 1, 2024 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J0577 in its code family, with their registry titles.